Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma
This study has been terminated.
( slow accrual and financial resource limitation )
Study NCT00476554 Information provided by Cyclacel Pharmaceuticals, Inc.
First Received on May 19, 2007. Last Updated on November 7, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cutaneous T-cell Lymphoma (CTCL)
Additional conditions recognized in this trial
Lymphoma, T-Cell, Cutaneous
More general conditions related to this trial
Immune System Diseases
Neoplasms by Histologic Type
Interventions listed in this trial
Sponsors listed in this trial
Cyclacel Pharmaceuticals, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers